Suven Life Sciences share news and announcements
NSE: SUVENBSE: 530239Healthcare ServicesSmall Cap
Last close ₹261.35down ₹6.85 (2.55%)BSE ₹261.80
Share price at the NSE close on 23 Oct 2026. Previous close ₹268.20.
52-week range of traded prices to 23 Oct 2026
₹124.11Low, 24 Mar 2026₹403.35High, 1 Sep 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹7,385 Cr806th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 6 Aug 2026
- −100.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 6 Aug 2026
- −63.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 13 May 2026
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 10,72,06841.2% delivered
Suven Life Sciences record dates, bonuses and splits
16 filed, newest first.
May 2024
May 2023
Nov 2022
Oct 2022
12 Oct · Corporate action
Jun 2022
24 Jun · Corporate action
May 2022
May 2021
Aug 2020
Jan 2020
Jan 2019
Jan 2018
Jan 2017
Mar 2016
Apr 2007
9 Apr · Corporate action
Share Transfer Committee of Board of Directors of the Company in its meeting held on April 06, 2007, has issued and allotted 5,76,33,250 equity shares of Re.1/- each in the ratio of (1:1) one equity share for every one equity share held by the members of the Company as per the Register of Members as on the Record Date.
Mar 2007
12 Mar · Corporate action
The members in Extra-Ordinary General Meeting held on 10th March 2007 have approved the Sub-division of equity shares from the face value of Rs.2/- each to face value of Re.1.00/- each and issue of Bonus shares 1:1 i.e. one equity share for every one equity share held as on the Record Date. The Board of Directors in their meeting held on 10th March 2007 at 12.30 p.m. has announced April 02, 2007 as the Record Date for the purpose of Sub-division of equity shares from face value of Rs.2/- each in to face value of Rs.1.00 each and issue of Bonus shares i.e. one equity share for every one equity share held
Jan 2007
29 Jan · Corporate action
The Board of Directors in their meeting held on 29th January 2007 have considered and approved the following matters: 1) Taken on Records the Un-audited financial results for the quarter ended 31st December 2006. 2) Approved the sub-division of equity shares from Face Value of Rs 2/- each to Face Value of Rs 1/- each subject to approval of members in general meeting and other approvals, if any. 3) Approved issue of Bonus equity shares in the ratio of (1:1) One equity share for every One equity share held by the members of the company, subject to approval of members in general meeting and other approvals, if any. The Extra-Ordinary General Meeting of the Company will be held on Saturday, 10th March 2007 for aproval of sub-division of equity shares and issue of bonus shares to the members as on the Record Date to be announced by the Board. Compensation committee of the Board met on 29th January 2007 and allotted 91,625 equity shares under the stock option plans of the company to the employees who have exercised the stock options. With this allotment the paid up capital of the company has gone up from 2,87,25,000 shares of Rs.2/- each aggregating Rs. 5,74,50,000 to 2,88,16,625 shares of Rs.2/- each aggregating Rs. 5,76,33,250/-